Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Firmagon

(FER-muh-gon)
A drug used to treat advanced prostate cancer. Firmagon binds to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland. This causes the testicles to stop making testosterone. Firmagon may stop the growth of cancer cells that need testosterone to grow. It is a type of GnRH antagonist. Also called degarelix acetate.
Search NCI's Dictionary of Cancer Terms